For monitoring the performance of teicoplanin susceptibility tests, the following quality control limits are recommended: Staphylococcus aureus ATCC 29213, MIC of 0.12 to 0.5 ,ug/ml; Enterococcusfaecalis ATCC 29212, MIC of 0.06 to 0.25 ,ug/ml; and S. aureus ATCC 25923, zones 15 to 19 mm in diameter (30-,ig disks). However, some lots of Mueller-Hinton agar provided unusually large zones of inhibition with both vancomycin and teicoplanin disks, and these lots should be excluded before routine use. Teicoplanin and vancomycin differed only in their activity against oxacillin-resistant strains of Staphylococcus haemolyticus, which had decreased susceptibility to teicoplanin but were fully susceptible to vancomycin. For tests with 30-,ig teicoplanin disks, zones <10 and .14 mm in diameter represent resistant and susceptible breakpoints, respectively.
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Teicoplanin is a complex of glycopeptide antibiotics which has a spectrum of antibacterial activity similar to that of vancomycin (la, 2, 5, 8-10) . Both drugs are primarily effective against gram-positive bacterial pathogens but not against gram-negative pathogens. The serum half-life of teicoplanin is markedly prolonged compared with that of vancomycin, but both drugs attain similar peak levels in blood (4, 10) .
For disk diffusion susceptibility tests, we previously recommended the use of 30-,ug teicoplanin disks, and tentative zone size interpretive criteria were proposed on the basis of studies performed in two separate laboratories with disks manufactured in one of the laboratories (la) . We now report the results of additional tests performed with commercially prepared disks (BBL Microbiology Systems, Cockeysville, Md.). In this confirmatory study, the coagulase-negative staphylococci were identified to the species level to better characterize any strains that were resistant to teicoplanin but susceptible to vancomycin.
Broth microdilution and disk diffusion susceptibility tests were performed in accordance with the procedures outlined by the National Committee for Clinical Laboratory Standards (6, 7) . Two separate collaborative studies were performed to identify quality control parameters for disk diffusion and microdilution tests. The study design was that described by Gavan et To confirm the previously proposed tentative zone size breakpoints (la) , 338 bacterial isolates were tested against vancomycin and teicoplanin ( (Table 3 ). The MIC and zone size breakpoints (horizontal and vertical fines) are those previously proposed (la).
1.0 ptg/ml), Branhamella catarrhalis strains also differed in their response to the two glycopeptides. Although these gram-negative microorganisms would normally be considered resistant to both drugs, 14 of 19 strains were intermediate in teicoplanin resistance (MIC, 8 .0 Ftg/ml), 3 were susceptible (MIC, 4.0 ,ug/ml), and 1 was resistant (MIC, 16 .ig/ml). However, all 19 strains were resistant to vancomycin (MICs, >16 ,ug/ml).
The correlation between zone sizes and vancomycin MIC are shown in Fig. 1 . Interpretive criteria that we have previously recommended (la) 
